Fagan Associates’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $11.7M | Sell |
|
|||||
|
2025
Q1 | $12.7M | Sell |
|
|||||
|
2024
Q4 | $10.7M | Buy |
|
|||||
|
2024
Q3 | $12.3M | Sell |
|
|||||
|
2024
Q2 | $12.4M | Buy |
|
|||||
|
2024
Q1 | $10.8M | Buy |
|
|||||
|
2023
Q4 | $10.4M | Buy |
|
|||||
|
2023
Q3 | $8.72M | Buy |
|
|||||
|
2023
Q2 | $8.65M | Buy |
|
|||||
|
2023
Q1 | $7.61M | Sell |
|
|||||
|
2022
Q4 | $7M | Buy |
|
|||||
|
2022
Q3 | $6.95M | Buy |
|
|||||
|
2022
Q2 | $6.68M | Sell |
|
|||||
|
2022
Q1 | $6.76M | Buy |
|
|||||
|
2021
Q4 | $5.14M | Buy |
|
|||||
|
2021
Q3 | $3.7M | Sell |
|
|||||
|
2021
Q2 | $4.32M | Buy |
|
|||||
|
2021
Q1 | $3.93M | Buy |
|
|||||
|
2020
Q4 | $878K | Buy |
|